A Nationwide Genomic Study of Clinical Klebsiella pneumoniae Carrying bla OXA-232 and rmtF in China
Year: 2023
Type: article
Abstract: In recent years, the detection rate of carbapenem-resistant K. pneumoniae has increased and represents a major threat to clinical anti-infective therapy. Compared with KPC-type carbapenemases and NDM-type metallo-β-lactamases, OXA-48 family carbapenemases are another important resistance mechanism mediating bacterial resistance to carbapenems. In this study, we investigated the molecular characteristics of OXA-232 carbapenemase-producing K. pneumoniae isolated from several hospitals to clarify the epidemiological dissemination characteristics of such drug-resistant strains in China.
Source: Microbiology Spectrum
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funders: Guangzhou Medical University, Harbin Medical University, Sir Run Run Shaw Hospital, Inner Mongolia Medical University, National Natural Science Foundation of China, Central South University, Anhui Medical University, Fudan University, Kunming Medical University, Jilin University, Ningxia Medical University, Tongji University, Chongqing Medical University, Zhejiang University, Xinjiang Medical University, Sichuan University, China Medical University, Peking Union Medical College Hospital, Xiamen University, Tianjin Medical University, Peking Union Medical College, Hebei Medical University, Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Henan Provincial People's Hospital, Ruijin Hospital, Nanjing Drum Tower Hospital, Xiangya Hospital, Central South University, West China Hospital, Sichuan University
OpenAlex ID: W4367174598